Total Payments
$6,936
2024 Payments
$15.20
Companies
31
Transactions
429
Medicare Patients
2,393
Medicare Billing
$163,022
Payment Breakdown by Category
Food & Beverage$6,931 (99.9%)
Education$5.40 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,931 | 428 | 99.9% |
| Education | $5.40 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,283 | 81 | $0 (2024) |
| AbbVie Inc. | $953.95 | 54 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $577.98 | 37 | $0 (2023) |
| Allergan, Inc. | $539.32 | 42 | $0 (2020) |
| GlaxoSmithKline, LLC. | $517.77 | 31 | $0 (2023) |
| PFIZER INC. | $401.88 | 27 | $0 (2023) |
| Eisai Inc. | $362.80 | 19 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $306.98 | 18 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $291.34 | 16 | $0 (2023) |
| Lilly USA, LLC | $273.52 | 19 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $15.20 | 1 | Novo Nordisk Inc ($15.20) |
| 2023 | $769.23 | 31 | AbbVie Inc. ($257.20) |
| 2022 | $811.15 | 46 | ABBVIE INC. ($298.96) |
| 2021 | $1,349 | 76 | AbbVie Inc. ($330.20) |
| 2020 | $947.53 | 58 | Allergan, Inc. ($213.64) |
| 2019 | $916.12 | 63 | Novo Nordisk Inc ($246.04) |
| 2018 | $1,077 | 81 | Novo Nordisk Inc ($186.50) |
| 2017 | $1,051 | 73 | Novo Nordisk Inc ($279.41) |
All Payment Transactions
429 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: Diabetes | ||||||
| 09/05/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.10 | General |
| Category: NEUROSCIENCE | ||||||
| 06/30/2023 | AbbVie Inc. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $23.37 | General |
| Category: IMMUNOLOGY | ||||||
| 06/22/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: Diabetes | ||||||
| 06/21/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.58 | General |
| Category: Gastroenterology | ||||||
| 06/16/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: RESPIRATORY | ||||||
| 06/14/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: Diabetes | ||||||
| 06/07/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $57.44 | General |
| Category: Oncology | ||||||
| 06/01/2023 | AbbVie Inc. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $25.75 | General |
| Category: NEUROSCIENCE | ||||||
| 05/23/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: NEUROSCIENCE | ||||||
| 05/19/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: NEUROSCIENCE | ||||||
| 05/12/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $24.27 | General |
| Category: INSOMNIA | ||||||
| 05/03/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: NEUROSCIENCE | ||||||
| 04/21/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: VACCINES | ||||||
| 04/18/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/04/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: INSOMNIA | ||||||
| 04/01/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: Diabetes | ||||||
| 03/30/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $95.40 | General |
| Category: Gastroenterology | ||||||
| 03/28/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: DIABETES | ||||||
| 03/24/2023 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: Diabetes | ||||||
| 03/15/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.94 | General |
| Category: NEUROSCIENCE | ||||||
| 02/28/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV | Food and Beverage | In-kind items and services | $17.79 | General |
| 02/23/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $95.40 | General |
| Category: NEUROSCIENCE | ||||||
| 02/22/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Gastroenterology | ||||||
| 02/14/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 211 | 248 | $74,558 | $15,949 |
| 2022 | 12 | 757 | 891 | $196,082 | $53,841 |
| 2021 | 10 | 643 | 808 | $178,769 | $45,764 |
| 2020 | 12 | 782 | 913 | $181,531 | $47,468 |
Total Patients
2,393
Total Services
2,860
Medicare Billing
$163,022
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 143 | 179 | $54,416 | $9,280 | 17.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 39 | 39 | $13,962 | $5,067 | 36.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 29 | 30 | $6,180 | $1,601 | 25.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 222 | 349 | $106,096 | $21,135 | 19.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 66 | 66 | $23,628 | $8,829 | 37.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 120 | 121 | $19,723 | $8,215 | 41.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 124 | 125 | $9,125 | $3,799 | 41.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 54 | 59 | $12,154 | $2,752 | 22.6% |
| 0134A | Fee covid-19 vac 14 res | Office | 2022 | 67 | 67 | $8,040 | $2,611 | 32.5% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 15 | 15 | $6,930 | $2,569 | 37.1% |
| 0064A | Adm sarscov2 50mcg/0.25mlbst | Office | 2022 | 29 | 29 | $2,900 | $1,138 | 39.3% |
| 0094A | Adm sarscov2 50 mcg/.5 mlbst | Office | 2022 | 25 | 25 | $2,500 | $975.83 | 39.0% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 11 | 11 | $2,629 | $943.03 | 35.9% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 11 | 11 | $1,408 | $478.17 | 34.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 13 | 13 | $949.00 | $395.17 | 41.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 223 | 381 | $115,824 | $23,755 | 20.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 52 | 52 | $16,692 | $6,986 | 41.9% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 75 | 76 | $11,552 | $4,947 | 42.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 65 | 70 | $14,420 | $3,249 | 22.5% |
| 0064A | Fee covid-19 vac 7 res | Office | 2021 | 65 | 65 | $6,500 | $2,563 | 39.4% |
| 0031A | Adm sarscov2 vac ad26 .5ml | Office | 2021 | 39 | 39 | $3,900 | $1,486 | 38.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 80 | 81 | $5,913 | $1,425 | 24.1% |
| 0011A | Adm sarscov2 100mcg/0.5ml1st | Office | 2021 | 15 | 15 | $1,500 | $577.78 | 38.5% |
| 0012A | Adm sarscov2 100mcg/0.5ml2nd | Office | 2021 | 13 | 13 | $1,300 | $495.24 | 38.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 16 | 16 | $1,168 | $280.34 | 24.0% |
About Dr. James Amerena, M.D
Dr. James Amerena, M.D is a Family Medicine healthcare provider based in Frederick, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/02/2005. The National Provider Identifier (NPI) number assigned to this provider is 1912981929.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Amerena, M.D has received a total of $6,936 in payments from pharmaceutical and medical device companies, with $15.20 received in 2024. These payments were reported across 429 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($6,931).
As a Medicare-enrolled provider, Amerena has provided services to 2,393 Medicare beneficiaries, totaling 2,860 services with total Medicare billing of $163,022. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Frederick, MD
- Active Since 12/02/2005
- Last Updated 08/02/2016
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1912981929
Products in Payments
- Ozempic (Drug) $612.31
- VRAYLAR (Drug) $558.82
- UBRELVY (Drug) $412.85
- FARXIGA (Drug) $373.06
- Dayvigo (Drug) $362.80
- XIFAXAN (Drug) $293.19
- JARDIANCE (Drug) $213.19
- Victoza (Drug) $191.30
- SHINGRIX (Biological) $190.64
- XARELTO (Drug) $179.89
- RYBELSUS (Drug) $142.12
- CHANTIX (Drug) $141.81
- TRELEGY ELLIPTA (Drug) $137.73
- SYNTHROID (Drug) $125.22
- SOLIQUA 100/33 (Biological) $122.57
- TRULICITY (Drug) $118.26
- LINZESS (Drug) $117.95
- NURTEC ODT (Drug) $112.26
- Tresiba (Drug) $111.42
- SYMBICORT (Drug) $98.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Frederick
Amreen Aziz, Md, MD
Family Medicine — Payments: $14,184
Family Medicine $14,184
Dr. Julio Menocal, Md, MD
Family Medicine — Payments: $8,160
Family Medicine $8,160
Edward Fisher, M.d, M.D
Family Medicine — Payments: $7,804
Family Medicine $7,804
Michael Lerner, M.d, M.D
Family Medicine — Payments: $5,650
Family Medicine $5,650
Dr. Zoe Ajebon, D.o, D.O
Family Medicine — Payments: $4,611
Family Medicine $4,611
Rebecca Herman-Smith, D.o, D.O
Family Medicine — Payments: $4,192
Family Medicine $4,192